✦ LIBER ✦

RITZ-5: randomized intravenous TeZosentan (an endothelin-A/B antagonist) for the treatment of pulmonary edema. A prospective, multicenter, double-blind, placebo-controlled study

✍ Scribed by E. Kaluski; I. Kobrin; R. Zimlichman

Book ID: 114347563
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 36 KB
Volume: 12
Category: Article
ISSN: 1062-1458
DOI: 10.1016/s1062-1458(03)00174-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

RITZ 5: Randomized intravenous TeZosenta

RITZ 5: Randomized intravenous TeZosentan (an endothelin ET-A/B antagonist) for the treatment of pulmonary edema: a prospective multicenter double blind Placebo controlled study

✍ Edo Kaluski; Reuven Tzimilchman; Alon Marmur; Oscar Krakov; Olga Milovanov; Avi 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 151 KB

RITZ-5: randomized intravenousTeZosentan

RITZ-5: randomized intravenousTeZosentan (an endothelin-A/B antagonist)for the treatment of pulmonary edema: A prospective, multicenter, double-blind, placebo-controlled study

✍ Edo Kaluski; Isaac Kobrin; Reuven Zimlichman; Alon Marmor; Oscar Krakov; Olga Mi 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 123 KB

Efficacy of montelukast, a leukotriene r

Efficacy of montelukast, a leukotriene receptor antagonist, for the treatment of dysmenorrhea: A prospective, double-blind, randomized, placebo-controlled study

✍ Hiroyuki Fujiwara; Ryo Konno; Sachiho Netsu; Kohei Odagiri; Akiyo Taneichi; Sato 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 236 KB

A randomized, double-blind, placebo-cont

A randomized, double-blind, placebo-controlled, prospective study of bosentan for the treatment of persistent pulmonary hypertension of the newborn

✍ Mohamed, W A; Ismail, M 📂 Article 📅 2011 🏛 Nature Publishing Group 🌐 English ⚖ 359 KB

A multicenter, prospective, randomized,

A multicenter, prospective, randomized, double-blind, placebo-controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for the treatment of pulmonary fibrosis in scleroderma

✍ Rachel K. Hoyles; Ross W. Ellis; Jessica Wellsbury; Belinda Lees; Pauline Newlan 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 156 KB 👁 2 views

## Abstract ## Objective The lack of randomized controlled trials (RCTs) in pulmonary fibrosis in systemic sclerosis (SSc) has hampered an evidence‐based approach to treatment. This RCT was undertaken to investigate the effects of intravenous (IV) cyclophosphamide (CYC) followed by azathioprine (A

A multicenter, randomized, double-blind,

A multicenter, randomized, double-blind, placebo-controlled trial of adjuvant methotrexate treatment for giant cell arteritis

✍ Gary S. Hoffman; Maria C. Cid; David B. Hellmann; Loic Guillevin; John H. Stone; 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 105 KB 👁 2 views